The Efficacy of Moxibustion on the Serum Levels of CXCL1 and β-EP in Patients with Rheumatoid Arthritis
Objective. This study aims to evaluate the efficacy of moxibustion on joint swelling and pain and the levels of C-X-C motif chemokine ligand 1 (CXCL1), β-endorphin (β-EP) in serum of rheumatoid arthritis (RA) patients and to investigate the anti-inflammatory and analgesic mechanism of moxibustion on...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-01-01
|
| Series: | Pain Research and Management |
| Online Access: | http://dx.doi.org/10.1155/2021/7466313 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832560589986070528 |
|---|---|
| author | Siyu Tao Xue Wang Chenxi Liao Yan Xiong Jie Tang Nannan Jiang Yuan Li Xinyue Hu Rouxian Shuai Yueyue Wang Ping Wu |
| author_facet | Siyu Tao Xue Wang Chenxi Liao Yan Xiong Jie Tang Nannan Jiang Yuan Li Xinyue Hu Rouxian Shuai Yueyue Wang Ping Wu |
| author_sort | Siyu Tao |
| collection | DOAJ |
| description | Objective. This study aims to evaluate the efficacy of moxibustion on joint swelling and pain and the levels of C-X-C motif chemokine ligand 1 (CXCL1), β-endorphin (β-EP) in serum of rheumatoid arthritis (RA) patients and to investigate the anti-inflammatory and analgesic mechanism of moxibustion on improving RA. Methods. Sixty-eight patients with RA were randomly and equally classified into the control and treatment groups. The control group was treated with routine drug therapy, while the treatment group received routine drug therapy and moxibustion. Both groups were treated for eight weeks. The symptoms and laboratory indicators of RA patients were compared in the two groups before and after intervention. Results. Sixty-one patients completed the study: four patients dropped out from the treatment group and three from the control group. Trial endpoints were change (∆) in symptoms, measured by Ritchie’s articular index (RAI), swollen joint count (SJC), and laboratory indicators, measured by the level of CXCL1, β-EP, tumor necrosis factor-a (TNF-α), and interleukin-1β (IL-1β). ∆RAI, ∆SJC, ∆CXCL1, ∆β-EP, ∆TNF-α, and ∆IL-1β in the treatment group were superior to the control group (13.50 [14.50] versus 6.00 [13.00] in ∆RAI, 4.00 [3.00] versus 2.00 [4.00] in ∆SJC, 0.04 ± 0.79 ng/mL versus -0.01 ± 0.86 ng/mL in ∆CXCL1, -2.43 [5.52] pg/mg versus -0.04 [4.09] pg/mg in ∆β-EP, 3.45 [5.90] pg/mL versus 1.55 [8.29] pg/mL in ∆TNF-α, and 6.15 ± 8.65 pg/mL versus 1.28 ± 8.51 pg/mL in ∆IL-1β; all P < 0.05). Conclusion. Moxibustion can improve the joint swelling and pain symptoms in patients with RA, which may be related to the fact that moxibustion can reduce the release of inflammatory factors in patients with RA and downregulate the level of CXCL1 and increase the level of β-EP at the same time. This trial is registered with ChiCTR-IOR-17012282. |
| format | Article |
| id | doaj-art-36c5c3fa4c1b42e8b7c2b973f6450be4 |
| institution | Kabale University |
| issn | 1203-6765 1918-1523 |
| language | English |
| publishDate | 2021-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Pain Research and Management |
| spelling | doaj-art-36c5c3fa4c1b42e8b7c2b973f6450be42025-02-03T01:27:06ZengWileyPain Research and Management1203-67651918-15232021-01-01202110.1155/2021/74663137466313The Efficacy of Moxibustion on the Serum Levels of CXCL1 and β-EP in Patients with Rheumatoid ArthritisSiyu Tao0Xue Wang1Chenxi Liao2Yan Xiong3Jie Tang4Nannan Jiang5Yuan Li6Xinyue Hu7Rouxian Shuai8Yueyue Wang9Ping Wu10Chengdu University of Traditional Chinese Medicine, Chengdu 610075, Sichuan Province, ChinaChengdu University of Traditional Chinese Medicine, Chengdu 610075, Sichuan Province, ChinaChengdu University of Traditional Chinese Medicine, Chengdu 610075, Sichuan Province, ChinaWest China Fourth Hospital, Chengdu 610075, Sichuan Province, ChinaChengdu University of Traditional Chinese Medicine, Chengdu 610075, Sichuan Province, ChinaChengdu University of Traditional Chinese Medicine, Chengdu 610075, Sichuan Province, ChinaChengdu University of Traditional Chinese Medicine Affiliated Hospital, Chengdu 610075, Sichuan Province, ChinaChengdu University of Traditional Chinese Medicine, Chengdu 610075, Sichuan Province, ChinaChengdu University of Traditional Chinese Medicine, Chengdu 610075, Sichuan Province, ChinaSichuan Integrative Medicine Hospital, Chengdu 610075, Sichuan Province, ChinaChengdu University of Traditional Chinese Medicine, Chengdu 610075, Sichuan Province, ChinaObjective. This study aims to evaluate the efficacy of moxibustion on joint swelling and pain and the levels of C-X-C motif chemokine ligand 1 (CXCL1), β-endorphin (β-EP) in serum of rheumatoid arthritis (RA) patients and to investigate the anti-inflammatory and analgesic mechanism of moxibustion on improving RA. Methods. Sixty-eight patients with RA were randomly and equally classified into the control and treatment groups. The control group was treated with routine drug therapy, while the treatment group received routine drug therapy and moxibustion. Both groups were treated for eight weeks. The symptoms and laboratory indicators of RA patients were compared in the two groups before and after intervention. Results. Sixty-one patients completed the study: four patients dropped out from the treatment group and three from the control group. Trial endpoints were change (∆) in symptoms, measured by Ritchie’s articular index (RAI), swollen joint count (SJC), and laboratory indicators, measured by the level of CXCL1, β-EP, tumor necrosis factor-a (TNF-α), and interleukin-1β (IL-1β). ∆RAI, ∆SJC, ∆CXCL1, ∆β-EP, ∆TNF-α, and ∆IL-1β in the treatment group were superior to the control group (13.50 [14.50] versus 6.00 [13.00] in ∆RAI, 4.00 [3.00] versus 2.00 [4.00] in ∆SJC, 0.04 ± 0.79 ng/mL versus -0.01 ± 0.86 ng/mL in ∆CXCL1, -2.43 [5.52] pg/mg versus -0.04 [4.09] pg/mg in ∆β-EP, 3.45 [5.90] pg/mL versus 1.55 [8.29] pg/mL in ∆TNF-α, and 6.15 ± 8.65 pg/mL versus 1.28 ± 8.51 pg/mL in ∆IL-1β; all P < 0.05). Conclusion. Moxibustion can improve the joint swelling and pain symptoms in patients with RA, which may be related to the fact that moxibustion can reduce the release of inflammatory factors in patients with RA and downregulate the level of CXCL1 and increase the level of β-EP at the same time. This trial is registered with ChiCTR-IOR-17012282.http://dx.doi.org/10.1155/2021/7466313 |
| spellingShingle | Siyu Tao Xue Wang Chenxi Liao Yan Xiong Jie Tang Nannan Jiang Yuan Li Xinyue Hu Rouxian Shuai Yueyue Wang Ping Wu The Efficacy of Moxibustion on the Serum Levels of CXCL1 and β-EP in Patients with Rheumatoid Arthritis Pain Research and Management |
| title | The Efficacy of Moxibustion on the Serum Levels of CXCL1 and β-EP in Patients with Rheumatoid Arthritis |
| title_full | The Efficacy of Moxibustion on the Serum Levels of CXCL1 and β-EP in Patients with Rheumatoid Arthritis |
| title_fullStr | The Efficacy of Moxibustion on the Serum Levels of CXCL1 and β-EP in Patients with Rheumatoid Arthritis |
| title_full_unstemmed | The Efficacy of Moxibustion on the Serum Levels of CXCL1 and β-EP in Patients with Rheumatoid Arthritis |
| title_short | The Efficacy of Moxibustion on the Serum Levels of CXCL1 and β-EP in Patients with Rheumatoid Arthritis |
| title_sort | efficacy of moxibustion on the serum levels of cxcl1 and β ep in patients with rheumatoid arthritis |
| url | http://dx.doi.org/10.1155/2021/7466313 |
| work_keys_str_mv | AT siyutao theefficacyofmoxibustionontheserumlevelsofcxcl1andbepinpatientswithrheumatoidarthritis AT xuewang theefficacyofmoxibustionontheserumlevelsofcxcl1andbepinpatientswithrheumatoidarthritis AT chenxiliao theefficacyofmoxibustionontheserumlevelsofcxcl1andbepinpatientswithrheumatoidarthritis AT yanxiong theefficacyofmoxibustionontheserumlevelsofcxcl1andbepinpatientswithrheumatoidarthritis AT jietang theefficacyofmoxibustionontheserumlevelsofcxcl1andbepinpatientswithrheumatoidarthritis AT nannanjiang theefficacyofmoxibustionontheserumlevelsofcxcl1andbepinpatientswithrheumatoidarthritis AT yuanli theefficacyofmoxibustionontheserumlevelsofcxcl1andbepinpatientswithrheumatoidarthritis AT xinyuehu theefficacyofmoxibustionontheserumlevelsofcxcl1andbepinpatientswithrheumatoidarthritis AT rouxianshuai theefficacyofmoxibustionontheserumlevelsofcxcl1andbepinpatientswithrheumatoidarthritis AT yueyuewang theefficacyofmoxibustionontheserumlevelsofcxcl1andbepinpatientswithrheumatoidarthritis AT pingwu theefficacyofmoxibustionontheserumlevelsofcxcl1andbepinpatientswithrheumatoidarthritis AT siyutao efficacyofmoxibustionontheserumlevelsofcxcl1andbepinpatientswithrheumatoidarthritis AT xuewang efficacyofmoxibustionontheserumlevelsofcxcl1andbepinpatientswithrheumatoidarthritis AT chenxiliao efficacyofmoxibustionontheserumlevelsofcxcl1andbepinpatientswithrheumatoidarthritis AT yanxiong efficacyofmoxibustionontheserumlevelsofcxcl1andbepinpatientswithrheumatoidarthritis AT jietang efficacyofmoxibustionontheserumlevelsofcxcl1andbepinpatientswithrheumatoidarthritis AT nannanjiang efficacyofmoxibustionontheserumlevelsofcxcl1andbepinpatientswithrheumatoidarthritis AT yuanli efficacyofmoxibustionontheserumlevelsofcxcl1andbepinpatientswithrheumatoidarthritis AT xinyuehu efficacyofmoxibustionontheserumlevelsofcxcl1andbepinpatientswithrheumatoidarthritis AT rouxianshuai efficacyofmoxibustionontheserumlevelsofcxcl1andbepinpatientswithrheumatoidarthritis AT yueyuewang efficacyofmoxibustionontheserumlevelsofcxcl1andbepinpatientswithrheumatoidarthritis AT pingwu efficacyofmoxibustionontheserumlevelsofcxcl1andbepinpatientswithrheumatoidarthritis |